Nevertheless, recent studies in animal models show that selective small molecules targeting the BET bromodomains-containing proteins that regulate c-Myc activity can downregulate the c-Myc transcriptional signaling, reduce tumor burden, and prolong survival. This evidence concerns the gene MYC and neoplasm.